StonvexLoading…
StonvexStonvexStonvexCore line items from PEP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-21 | Annual 2025 2025-12-27 | Q3 2025 2025-09-06 | Q2 2025 2025-06-14 |
|---|---|---|---|---|
Revenue | $19.44B | $93.92B | $64.58B | $40.65B |
Operating Income | $3.21B | $11.50B | $7.94B | $4.37B |
Net Income | $2.33B | $8.24B | $5.70B | $3.10B |
EPS (Diluted) | $1.70 | $6.00 | $4.15 | $2.25 |
Total Assets | $110.65B | $107.40B | $106.56B | $105.34B |
Total Liabilities | $89.11B | $86.85B | $87.02B | $86.79B |
Cash & Equivalents | $10.47B | $9.16B | $8.13B | $7.63B |
Free Cash Flow OCF − CapEx | $-406.00M | $7.67B | $2.97B | $-511.00M |
Shares Outstanding | 1.37B | 1.37B | 1.37B | 1.37B |